Anticholinergic Drugs Market 2020 Top Industry Players Pfizer Inc. (US), Allergan Plc (US), Astellas Pharma Inc. (Japan), Johnson & Johnson Services Inc. (US)
Anticholinergic Drugs Market: Information by Type (Synthetic Compounds, Natural, Semi-Synthetic Compounds), Application (Overactive Bladder, Parkinson’s Disease, Chronic Obstructive Pulmonary Disease, Muscle Spasms, Irritable Bowel Syndrome), Route of Administration (Oral, Parenteral, Topical), End User (Hospitals and Pharmacies) and Region - Forecast till 2027
The Global Anticholinergic
Drugs Market is expected to register
a CAGR of 4.50% during the forecast period with a market value
of USD 7,149.90 million till 2024. Anticholinergics drugs are a broad
class of drugs that block acetylcholine-mediated neurotransmission in the
smooth muscle, heart, central, and peripheral nervous systems. Acetylcholine is
a neurotransmitter, or a chemical messenger released by nerve cells to send signals
to other cells.
The increasing prevalence of chronic diseases and increasing
investments and funding in the field of life science research has led to the
growth of the global anticholinergic drugs market in recent years. Moreover,
the aging population is expected to fuel market growth. However, side-effects
of anticholinergic drugs and stringent regulations are projected to hamper the
growth of the market during the assessment period.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/7895
Anticholinergic Drugs Market Studied By Top Players
Market Research Future (MRFR) recognizes following companies as
key players in the global anticholinergic drugs market that include Pfizer Inc. (US), Allergan Plc (US),
Astellas Pharma Inc. (Japan), Johnson & Johnson Services Inc. (US), Teva
Pharmaceutical Industries Ltd (Israel), Sanofi (France), GlaxoSmithKline Plc
(UK), Boehringer Ingelheim International GmbH (Germany) and others.
Anticholinergic Drugs Market- Segment Analysis
The anticholinergic drugs market, based on product type, has been
segmented into synthetic compounds, natural, semi-synthetic compounds. The
anticholinergic drugs market, based on application, has been segmented into the
overactive bladder, Parkinson’s disease, chronic obstructive pulmonary disease,
muscle spasms, irritable bowel syndrome. On the basis of route of
administration, the market is segmented into oral, parenteral, topical. On the basis
of end user, the market is segmented into hospitals and pharmacies.
Regional
Analysis
The Global Anticholinergic Drugs Market, based on
region, is divided into the Americas, Europe, Asia-Pacific, and the Middle East
and Africa.
The Americas is expected to hold the largest share of the
global anticholinergic drugs market. This owes to the rising
geriatric population along with the high prevalence of CNS diseases and demand
for effective therapies. The Europe market demonstrated substantial growth in the
market due to the rising prevalence of bladder overactivity, increasing
geriatric population, and rising healthcare expenditure. Germany held a share
of 25.8% in
the Western Europe anticholinergic drugs market in 2018. Asia-Pacific
is estimated to be the fastest growing region in the global market due to the
presence of a large number of research organizations and development of new
infrastructure to support the healthcare industry. Also, the Middle East and
Africa region is expected to show the least growth owing to low per capita
income and lack of adequate healthcare spending.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/anticholinergic-drugs-market-7895
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Comments
Post a Comment